These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 33655862
21. Design and synthesis of 2-phenylpyrimidine coumarin derivatives as anticancer agents. Lv N, Sun M, Liu C, Li J. Bioorg Med Chem Lett; 2017 Oct 01; 27(19):4578-4581. PubMed ID: 28888820 [Abstract] [Full Text] [Related]
22. A review of coumarin derivatives in pharmacotherapy of breast cancer. Musa MA, Cooperwood JS, Khan MO. Curr Med Chem; 2008 Oct 01; 15(26):2664-79. PubMed ID: 18991629 [Abstract] [Full Text] [Related]
23. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids. Kraljević TG, Harej A, Sedić M, Pavelić SK, Stepanić V, Drenjančević D, Talapko J, Raić-Malić S. Eur J Med Chem; 2016 Nov 29; 124():794-808. PubMed ID: 27639370 [Abstract] [Full Text] [Related]
24. Design, Synthesis, and In Vitro Evaluation of Novel 3, 7-Disubstituted Coumarin Derivatives as Potent Anticancer Agents. Wang Y, Liu H, Lu P, Mao R, Xue X, Fan C, She J. Chem Biol Drug Des; 2015 Oct 29; 86(4):637-47. PubMed ID: 25626768 [Abstract] [Full Text] [Related]
25. Synthesis and anticancer activities of some new coumarin derivatives including the triazole ring and their in silico molecular docking studies. Menteşe E, Güner A, Polatlı E, Emirik M, Bektaş H, Kahveci B. Arch Pharm (Weinheim); 2021 Mar 29; 354(3):e2000284. PubMed ID: 33146895 [Abstract] [Full Text] [Related]
26. Structure-activity relationship of natural and synthetic coumarin derivatives against Mycobacterium tuberculosis. Pires CT, Scodro RB, Cortez DA, Brenzan MA, Siqueira VL, Caleffi-Ferracioli KR, Vieira LC, Monteiro JL, Corrêa AG, Cardoso RF. Future Med Chem; 2020 Sep 29; 12(17):1533-1546. PubMed ID: 32820960 [Abstract] [Full Text] [Related]
27. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity. Paul K, Bindal S, Luxami V. Bioorg Med Chem Lett; 2013 Jun 15; 23(12):3667-72. PubMed ID: 23642480 [Abstract] [Full Text] [Related]
28. Coumarin-based derivatives with potential anti-HIV activity. Xu Z, Chen Q, Zhang Y, Liang C. Fitoterapia; 2021 Apr 15; 150():104863. PubMed ID: 33582266 [Abstract] [Full Text] [Related]
29. Anticancer Activity Study of Chromone and Coumarin Hybrids using Electrical Impedance Spectroscopy. Bouhenna MM, Mameri N, Pérez MV, Talhi O, Bachari K, Silva AMS, Luyten W. Anticancer Agents Med Chem; 2018 Apr 15; 18(6):854-864. PubMed ID: 29380706 [Abstract] [Full Text] [Related]
30. Coumarin: a promising scaffold for anticancer agents. Kaur M, Kohli S, Sandhu S, Bansal Y, Bansal G. Anticancer Agents Med Chem; 2015 Apr 15; 15(8):1032-48. PubMed ID: 25553437 [Abstract] [Full Text] [Related]
31. Design, Synthesis and Biological Evaluation of Novel Coumarin-Based Hydroxamate Derivatives as Histone Deacetylase (Hdac) Inhibitors with Antitumor Activities. Yang F, Zhao N, Song J, Zhu K, Jiang CS, Shan P, Zhang H. Molecules; 2019 Jul 15; 24(14):. PubMed ID: 31311163 [Abstract] [Full Text] [Related]
32. Synthesis and Evaluation of Cytotoxicity of Novel Coumarin Peptide Alcohol Derivatives. Pawar DS, Chabukswar VV, Tapase SR, Kodam KM, Chabukswar A, Adhav PB, Diwate BB, Gawali SS, Dallavalle S, Jagdale SC. Med Chem; 2021 Jul 15; 17(8):926-936. PubMed ID: 32807064 [Abstract] [Full Text] [Related]
33. Human estrogen receptor α antagonists, part 2: Synthesis driven by rational design, in vitro antiproliferative, and in vivo anticancer evaluation of innovative coumarin-related antiestrogens as breast cancer suppressants. Kurtanović N, Tomašević N, Matić S, Mitrović MM, Kostić DA, Sabatino M, Antonini L, Ragno R, Mladenović M. Eur J Med Chem; 2022 Jan 05; 227():113869. PubMed ID: 34710747 [Abstract] [Full Text] [Related]
34. Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies. Thakur A, Singla R, Jaitak V. Eur J Med Chem; 2015 Aug 28; 101():476-95. PubMed ID: 26188907 [Abstract] [Full Text] [Related]
35. Design, synthesis, and evaluation of novel coumarin-dithiocarbamate derivatives (IDs) as anti-colorectal cancer agents. Zhu H, Ying S, Zhou B, Hu X, Liang X, Li W, Wang D, Jin H, Pan Y. J Enzyme Inhib Med Chem; 2021 Dec 28; 36(1):593-604. PubMed ID: 33557648 [Abstract] [Full Text] [Related]
36. Synthesis and biological evaluation of novel coumarin-pyrazoline hybrids endowed with phenylsulfonyl moiety as antitumor agents. Amin KM, Eissa AA, Abou-Seri SM, Awadallah FM, Hassan GS. Eur J Med Chem; 2013 Feb 28; 60():187-98. PubMed ID: 23291120 [Abstract] [Full Text] [Related]
37. Strong in vitro and vivo cytotoxicity of novel organoplatinum(II) complexes with quinoline-coumarin derivatives. Qin QP, Wang ZF, Huang XL, Tan MX, Zou BQ, Liang H. Eur J Med Chem; 2019 Dec 15; 184():111751. PubMed ID: 31593828 [Abstract] [Full Text] [Related]
38. Synthesis of novel building blocks of benzosuberone bearing coumarin moieties and their evaluation as potential anticancer agents. Yadagiri B, Holagunda UD, Bantu R, Nagarapu L, Kumar CG, Pombala S, Sridhar B. Eur J Med Chem; 2014 May 22; 79():260-5. PubMed ID: 24742385 [Abstract] [Full Text] [Related]
39. Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents. Zhang W, Li Z, Zhou M, Wu F, Hou X, Luo H, Liu H, Han X, Yan G, Ding Z, Li R. Bioorg Med Chem Lett; 2014 Feb 01; 24(3):799-807. PubMed ID: 24418772 [Abstract] [Full Text] [Related]
40. DNA-binding activity and cytotoxic and cell-cycle arrest properties of some new coumarin derivatives: a multispectral and computational investigation. Khosravifar F, Dehghan G, Bidoki SK, Mahdavi M. Luminescence; 2020 Feb 01; 35(1):98-106. PubMed ID: 31475787 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]